In a trial of nearly 3,000 participants, researchers found 25 percent of participants mistakenly believed the FDA approves only drugs without serious side effects, and more than one-third mistakenly believed that the FDA approves only “extremely effective” drugs, according to a Dartmouth College release.
Read the full report in Becker’s Hospital Review on the medication safety study.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.